FDA: New Steps to improve Supply Chain Security

Recommendation
14-16 May 2025
Vienna / Schwechat, Austria
Two-day training + 1-day Airport tour at Vienna Airport in cooperation with DHL
The FDA supports the adoption of more modern technologies for improving the security of the drug supply chain. Innovations should improve tracking and tracing of medicines.
Now FDA is launching a new pilot project in which participants representing the drug supply chain (e.g., manufacturers, repackagers and other stakeholders) can pilot the use of innovative and emerging approaches for enhanced tracing and verification. Currently the project is focusing on prescription drugs in the U.S., with the aim to prevent suspicious and illegitimate products from entering the supply chain.
The intention of the so-called "Pilot Project Program Under the Drug Supply Chain Security Act" (DSCSA Pilot Project Program) is to assist FDA and members of the pharmaceutical distribution supply chain in the development of an electronic, interoperable system.
Related GMP News
23.04.2025MHRA Class 2 Recall due to Blister Pack Mislabeling
15.04.2025Falsified Medicinal Products: Swissmedic Intensifies Controls on International Trade
15.04.2025EMA's 3-Year Work Plan for GMDP Inspectors Working Group: What's Planned for GDP?
15.04.2025Two GDP Non-Compliance Reports published in March
15.04.2025Visit the DHL Vienna Airport Campus
15.04.2025Questions and Answers from the ECA Webinar "GDP Update 2025" - Part 1